Journal of Antimicrobial Chemotherapy · 2007 · 264 citations · 4 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceBacteriologyMedical MicrobiologyAntibacterial ResistanceAntibiotic ResistanceMolecular Epidemiology Of ResistanceResistance EpidemiologyResistance GenesAcinetobacter Baumannii ResistanceAntimicrobial Resistance Gene DetectionAntimicrobial Resistance PatternsBacterial Resistance DetectionDrug Resistance Pattern AnalysisPathogen Resistance TestingPhenotypic Susceptibility ProfilingResistance In Clinical Isolates
OBJECTIVES: To investigate antimicrobial resistance in clinical isolates of Acinetobacter spp. from two Korean hospitals. METHODS: Two hundred and sixty-five isolates of Acinetobacter spp. from two Korean hospitals were collected and were identified to species level using partial rpoB gene sequences. Antimicrobial susceptibility testing was performed using a broth microdilution method. RESULTS: rpoB gene sequences indicated that 214 isolates (80.8%) were Acinetobacter baumannii, and allowed these to be classified into three subgroups (I, II and III); 142 isolates (53.6%) belonged to subgroup I, 54 (20.4%) to subgroup II and 18 (6.8%) to subgroup III. Forty-eight isolates (18.1%) and 74 isolates (27.9%) were resistant to polymyxin B and colistin, respectively. However, antimicrobial resistance rates varied markedly between subgroups. While A. baumannii subgroup I showed low resistance rates to polymyxin B and colistin (2.1% and 7.0%, respectively), subgroups II and III showed high resistance rates to these antibiotics (38.9% and 64.8% in subgroup II and 72.2% and 88.9%, in subgroup III, respectively). Multidrug resistance was also significantly more frequent in subgroup I (45.1%) than in subgroups II and III (13.0% and 16.7%, respectively). CONCLUSIONS: Our data indicate that subgroup identification of A. baumannii may aid selection of appropriate antimicrobial agents for the treatment of Acinetobacter infections.
4
Ana Cristina Gales, Ronald N. Jones, Hélio S. Sader · Clinical Microbiology and Infection · 2006 · 308 citations · Full text
Mark E. Jones, Deborah C. Draghi, Clyde Thornsberry et al. · Annals of Clinical Microbiology and Antimicrobials · 2004 · 272 citations · Full text